Skip to main content
Erschienen in: Clinical Rheumatology 12/2007

01.12.2007 | Review Article

Capillaroscopy: questions and answers

verfasst von: Walter Grassi, Rossella De Angelis

Erschienen in: Clinical Rheumatology | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Capillaroscopy is an essential imaging technique used in the study of microcirculation and one of the best diagnostic tools for the early detection of systemic sclerosis and related conditions. However, despite the increasing interest in capillary microscopy, there is still a surprising discrepancy between its potential application and its still limited use in rheumatological practice. This contrast is really surprising because few diagnostic techniques can combine all the positive features typical of capillaroscopy (low cost, uninvasiveness, repeatability, high sensitivity, good specificity, easy interpretation of results). The lack of guidelines and recommendations concerning the right way to carry out a correct capillaroscopic examination and the interpretation of the most relevant capillaroscopic abnormalities may represent one of the major drawbacks for its widespread use. Discussion about controversies on this topic should be encouraged, leading to a progressive development of capillaroscopy as a routine investigation in rheumatology.
Literatur
2.
Zurück zum Zitat Houtman PM, Kallenberg CGM, Fidler V et al (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. J Rheumatol 13:556–563PubMed Houtman PM, Kallenberg CGM, Fidler V et al (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. J Rheumatol 13:556–563PubMed
3.
Zurück zum Zitat Statham BN, Rowell NR (1986) Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud’s phenomenon. Acta Derm Venereol 66:139–143PubMed Statham BN, Rowell NR (1986) Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud’s phenomenon. Acta Derm Venereol 66:139–143PubMed
4.
Zurück zum Zitat Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91PubMed Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91PubMed
5.
6.
Zurück zum Zitat Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749CrossRefPubMedPubMedCentral Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Scheja A, Akesson A, Niewierowicz I et al (1996) Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 55:52–56CrossRefPubMedPubMedCentral Scheja A, Akesson A, Niewierowicz I et al (1996) Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 55:52–56CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822CrossRefPubMed Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822CrossRefPubMed
9.
Zurück zum Zitat Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28:496–501CrossRefPubMed Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28:496–501CrossRefPubMed
10.
Zurück zum Zitat Schmidt KU, Mensing H (1988) Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 176:18–21CrossRefPubMed Schmidt KU, Mensing H (1988) Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 176:18–21CrossRefPubMed
11.
Zurück zum Zitat Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
12.
13.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed
14.
Zurück zum Zitat Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030CrossRefPubMed Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030CrossRefPubMed
15.
Zurück zum Zitat Grassi W, Del Medico P, Izzo F et al (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 30:397–402CrossRefPubMed Grassi W, Del Medico P, Izzo F et al (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 30:397–402CrossRefPubMed
16.
Zurück zum Zitat Anders HJ, Sigl T, Schattenkirchner N (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophtalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMedPubMedCentral Anders HJ, Sigl T, Schattenkirchner N (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophtalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nailfold capillaroscopic instrument. Arch Dermatol 139:1027–1030CrossRefPubMed Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nailfold capillaroscopic instrument. Arch Dermatol 139:1027–1030CrossRefPubMed
18.
Zurück zum Zitat Tektonidou M, Kaskani E, Skopouli FN et al (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830CrossRefPubMed Tektonidou M, Kaskani E, Skopouli FN et al (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830CrossRefPubMed
19.
Zurück zum Zitat Rozboril MB, Maricq HR, Rodnan GP et al (1983) Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum 26:617–622CrossRefPubMed Rozboril MB, Maricq HR, Rodnan GP et al (1983) Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum 26:617–622CrossRefPubMed
20.
Zurück zum Zitat Zaric D, Worm AM, Stahl D et al (1981) Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol 10:249–252CrossRefPubMed Zaric D, Worm AM, Stahl D et al (1981) Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol 10:249–252CrossRefPubMed
21.
Zurück zum Zitat Grassi W, Core P, Carlino G et al (1992) Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol 21:226–230CrossRefPubMed Grassi W, Core P, Carlino G et al (1992) Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol 21:226–230CrossRefPubMed
22.
Zurück zum Zitat Dinc A, Melikoglu M, Korkmaz C et al (2001) Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol 19(Suppl 24):S42–S44PubMed Dinc A, Melikoglu M, Korkmaz C et al (2001) Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol 19(Suppl 24):S42–S44PubMed
23.
Zurück zum Zitat Vaiopoulos G, Pangratis N, Samarkos M et al (1995) Nailfold capillary abnormalities in Behçet’s disease. J Rheumatol 22:1108–1111PubMed Vaiopoulos G, Pangratis N, Samarkos M et al (1995) Nailfold capillary abnormalities in Behçet’s disease. J Rheumatol 22:1108–1111PubMed
24.
Zurück zum Zitat Sulli A, Pizzorni C, Cutolo M (2000) Nailfold videocapillaroscopy in patients with antiphospholipid antibodies. J Rheumatol 27:1574–1576PubMed Sulli A, Pizzorni C, Cutolo M (2000) Nailfold videocapillaroscopy in patients with antiphospholipid antibodies. J Rheumatol 27:1574–1576PubMed
25.
Zurück zum Zitat Grassi W, Core P, Carlino G et al (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed Grassi W, Core P, Carlino G et al (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed
26.
Zurück zum Zitat Fahrig C, Heidrich H, Voigt B et al (1995) Capillary microscopy of the nailfold in healthy subjects. Int J Microcirc Clin Exp 15:287–292CrossRefPubMed Fahrig C, Heidrich H, Voigt B et al (1995) Capillary microscopy of the nailfold in healthy subjects. Int J Microcirc Clin Exp 15:287–292CrossRefPubMed
27.
Zurück zum Zitat Herrick AL, Moore T, Hollis S et al (2000) The influence of age on nailfold capillary dimensions in childhood. J Rheumatol 27:797–800PubMed Herrick AL, Moore T, Hollis S et al (2000) The influence of age on nailfold capillary dimensions in childhood. J Rheumatol 27:797–800PubMed
28.
Zurück zum Zitat Merlen JF (1985) Capillaroscopy at the nailbed in functioning people aged 70 and over. Int Angiol 4:285–288PubMed Merlen JF (1985) Capillaroscopy at the nailbed in functioning people aged 70 and over. Int Angiol 4:285–288PubMed
29.
Zurück zum Zitat Michoud E, Poensin D, Carpentier PH (1994) Digitized nailfold capillaroscopy. Vasa 23:35–42PubMed Michoud E, Poensin D, Carpentier PH (1994) Digitized nailfold capillaroscopy. Vasa 23:35–42PubMed
30.
Zurück zum Zitat Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video-capillaroscopy. Rheumatology 39:506–512CrossRefPubMed Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video-capillaroscopy. Rheumatology 39:506–512CrossRefPubMed
31.
Zurück zum Zitat Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold videocapillaroscopy. A new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848PubMed Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold videocapillaroscopy. A new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848PubMed
32.
Zurück zum Zitat Leteurtre E, Hachulla E, Janin A et al (1994) Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 15:800–807CrossRefPubMed Leteurtre E, Hachulla E, Janin A et al (1994) Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 15:800–807CrossRefPubMed
33.
Zurück zum Zitat De Angelis R, Bugatti L, Del Medico P et al (2002) Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 204:236–239CrossRefPubMed De Angelis R, Bugatti L, Del Medico P et al (2002) Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 204:236–239CrossRefPubMed
34.
Zurück zum Zitat Chang CH, Tsai RK, Wu WC et al (1997) Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. Microvasc Res 53:121–127CrossRefPubMed Chang CH, Tsai RK, Wu WC et al (1997) Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. Microvasc Res 53:121–127CrossRefPubMed
35.
Zurück zum Zitat Monticone G, Colonna L, Palermi G et al (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis. J Am Acad Dermatol 42:787–790CrossRefPubMed Monticone G, Colonna L, Palermi G et al (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis. J Am Acad Dermatol 42:787–790CrossRefPubMed
36.
Zurück zum Zitat Fitzgerald O, C’Connor GT, Spencer-Green G (1988) Prospective study on the evolution of Raynaud’s phenomenon. Am J Med 84:718–726CrossRefPubMed Fitzgerald O, C’Connor GT, Spencer-Green G (1988) Prospective study on the evolution of Raynaud’s phenomenon. Am J Med 84:718–726CrossRefPubMed
37.
Zurück zum Zitat Spencer-Green G (1998) Outcomes in primary Raynaud’s phenomenon. A meta-analysis of frequency, rates and predictors of transition to secondary disease. Arch Intern Med 158:595–600CrossRefPubMed Spencer-Green G (1998) Outcomes in primary Raynaud’s phenomenon. A meta-analysis of frequency, rates and predictors of transition to secondary disease. Arch Intern Med 158:595–600CrossRefPubMed
38.
Zurück zum Zitat Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed
39.
Zurück zum Zitat Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud’s phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud’s phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed
40.
Zurück zum Zitat ter Borg EJ, Piersma-Wichers G, Smit AJ et al (1994) Serial nailfold capillary microscopy in primary Raynaud’s phenomenon and scleroderma. Semin Arthritis Rheum 24:40–47CrossRefPubMed ter Borg EJ, Piersma-Wichers G, Smit AJ et al (1994) Serial nailfold capillary microscopy in primary Raynaud’s phenomenon and scleroderma. Semin Arthritis Rheum 24:40–47CrossRefPubMed
41.
Zurück zum Zitat Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294PubMed Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294PubMed
42.
Zurück zum Zitat Kabasakal Y, Elvins DM, Ring EFJ et al (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512CrossRefPubMedPubMedCentral Kabasakal Y, Elvins DM, Ring EFJ et al (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed
44.
Zurück zum Zitat Jayson MIV (1984) The microcirculation in systemic sclerosis. Clin Exp Rheumatol 2:85–91PubMed Jayson MIV (1984) The microcirculation in systemic sclerosis. Clin Exp Rheumatol 2:85–91PubMed
45.
Zurück zum Zitat Wigley FM, Wise RA, Miller R et al (1992) Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688–693CrossRefPubMed Wigley FM, Wise RA, Miller R et al (1992) Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688–693CrossRefPubMed
46.
Zurück zum Zitat Grassi W, Core P, Carlino G et al (1994) Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 37:384–390CrossRefPubMed Grassi W, Core P, Carlino G et al (1994) Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 37:384–390CrossRefPubMed
47.
Zurück zum Zitat Filaci G, Cutolo M, Scudeletti M et al (1999) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 38:992–996CrossRefPubMed Filaci G, Cutolo M, Scudeletti M et al (1999) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 38:992–996CrossRefPubMed
48.
Zurück zum Zitat Faggioli P, Giani L, Mazzone A (2006) Possibile role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 24:220PubMed Faggioli P, Giani L, Mazzone A (2006) Possibile role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 24:220PubMed
Metadaten
Titel
Capillaroscopy: questions and answers
verfasst von
Walter Grassi
Rossella De Angelis
Publikationsdatum
01.12.2007
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0681-3

Weitere Artikel der Ausgabe 12/2007

Clinical Rheumatology 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.